Dec 2025Revenue $7.50M/yrExpenses $18.2M/yr
No trendCash runway ≈ 10 months from Dec 2025
Figures by year
When will COSCIENS Biopharma be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $7.50M and expenses $18.2M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $7.50M | $18.2M | −$10.7M |
| Dec 2024 | $9.59M | $27.9M | −$18.3M |
| Dec 2023 | $7.14M | $11.8M | −$4.63M |
| Dec 2022 | $14.6M | $10.3M | $4.32M |
| Dec 2021 | $5.26M | $13.9M | −$8.67M |
| Dec 2020 | $3.65M | $9.36M | −$5.71M |
| Dec 2019 | $532K | $10.8M | −$10.2M |
| Dec 2018 | $26.9M | $17.0M | $9.84M |
| Dec 2017 | $923K | $24.0M | −$23.1M |
| Dec 2016 | $911K | $30.4M | −$29.5M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.